Early postmyocardial infarction survival in Murphy Roths Large mice is mediated by attenuated apoptosis and inflammation but depends on genetic background

Experimental Physiology

Volumn 97, Issue 1, 2012, Pages 102-114

  Hunt, Darlene L ^a   Campbell, Patrick H ^a   Zambon, Alexander C ^a   Vranizan, Karen ^b,c   Evans, Sylvia M ^a   Kuo, Hai Chien ^d   Yamaguchi, Ken D ^d   Omens, Jeffrey H ^a   McCulloch, Andrew D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL MOUSE; CARDITIS; CONTROLLED STUDY; GENETIC DIFFERENCE; GENETIC TRAIT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART STRESS; HEART VENTRICLE HYPERTROPHY; MALE; MICROARRAY ANALYSIS; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NICK END LABELING; NONHUMAN; SCAR; SURVIVAL;

EID: 84355161600     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.060269     Document Type: Article

References (51)

1. The Jackson Laboratories JAX® Mice Data Sheet, Stock No. 000486, vol. 2006.
2. Abdullah I, Lepore JJ, Epstein JA, Parmacek MS & Gruber PJ (2005). MRL mice fail to heal the heart in response to ischemia-reperfusion injury. Wound Repair Regen 13, 205-208.
3. Ashton KJ & Headrick JP (2007). Quantitative (real-time) RT-PCR in cardiovascular research. In Cardiac Gene Expression: Methods and Protocols, vol. 366, ed. Zhang J & Rokosh G, pp. 121-143. Humana Press, Totowa, NJ.
4. Askari AT, Brennan M-L, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL & Penn MS (2003). Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 197, 615-624.
5. Au PYB, Martin N, Chau H, Moemeni B, Chia M, Liu F-F, Minden M & Yeh W-C (2005). The oncogene PDGF-B provides a key switch from cell death to survival induced by TNF. Oncogene 24, 3196-3205.
6. Blankenhorn E, Bryan G, Kossenkov A, Clark L, Zhang X-M, Chang C, Horng W, Pletscher L, Cheverud J, Showe L & Heber-Katz E (2009). Genetic loci that regulate healing and regeneration in LG/J and SM/J mice. Mamm Genome 20, 720-733.
7. Boyle MP & Weisman HF (1993). Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation 88, 2872-2883.
8. Brunner S, Winogradow J, Huber BC, Zaruba M-M, Fischer R, David R, Assmann G, Herbach N, Wanke R, Mueller-Hoecker J & Franz W-M (2009). Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. FASEB J 23, 351-361.
9. Campbell P, Hunt D, Jones Y, Harwood F, Omens JH & McCulloch AD (2008). Effects of biglycan deficiency on myocardial infarct structure and mechanics. Mol Cell Biomech 5, 27-35.
10. Cavasin MA, Sankey SS, Yu A-L, Menon S & Yang X-P (2003). Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284, H1560-H1569.
11. Chen J, Tung C-H, Allport JR, Chen S, Weissleder R & Huang PL (2005). Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation 111, 1800-1805.
12. Cimini M, Fazel S, Fujii H, Zhou S, Tang G, Weisel RD & Li R-K (2008). The MRL mouse heart does not recover ventricular function after a myocardial infarction. Cardiovasc Pathol 17, 32-39.
13. Clark LD, Clark RK & Heber-Katz E (1998). A new murine model for mammalian wound repair and regeneration. Clin Immunol Immunopathol 88, 35-45.
14. Doniger S, Salomonis N, Dahlquist K, Vranizan K, Lawlor S & Conklin B (2003). MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4, R7.
15. Erlich JH, Boyle EM, Labriola J, Kovacich JC, Santucci RA, Fearns C, Morgan EN, Yun W, Luther T, Kojikawa O, Martin TR, Pohlman TH, Verrier ED & Mackman N (2000). Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 157, 1849-1862.
16. Gao X-M, Xu Q, Kiriazis H, Dart AM & Du X-J (2005). Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 65, 469-477.
17. Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini A, Sawitzki G, Smith C, Smyth G, Tierney L, Yang J & Zhang J (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5, R80.
18. Grisel P, Meinhardt A, Lehr H-A, Kappenberger L, Barrandon Y & Vassalli G (2008). The MRL mouse repairs both cryogenic and ischemic myocardial infarcts with scar. Cardiovasc Pathol 17, 14-22.
19. Harpster M, Bandyopadhyay S, Thomas D, Ivanov P, Keele J, Pineguina N, Gao B, Amarendran V, Gomelsky M, McCormick R & Stayton M (2006). Earliest changes in the left ventricular transcriptome post-myocardial infarction. Mamm Genome 17, 701-715.
20. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T & Takeshita A (2003). Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285, H1229-H1235.
21. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JPM, Shipley M, Angellilo A, Levi M, Nüße O, Baker A, Keshet E, Lupu F, Herbert J-M, Smits JFM, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJAP & Carmeliet P (1999). Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5, 1135-1142.
22. Hutchins G & Bulkley B (1978). Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 41, 1127-1132.
23. Johns TNP & Olson BJ (1954). Experimental myocardial infarction: a method of coronary occlusion in small animals. Ann Surg 140, 675-682.
24. Leferovich JM, Bedelbaeva K, Samulewicz S, Zhang X-M, Zwas D, Lankford EB & Heber-Katz E (2001). Heart regeneration in adult MRL mice. PNAS 98, 9830-9835.
25. Li X, Gu W, Masinde G, Hamilton-Ulland M, Xu S, Mohan S & Baylink DJ (2001). Genetic control of the rate of wound healing in mice. Heredity 86, 668-674.
26. Liehn EA, Merx MW, Postea O, Becher S, Djalali-Talab Y, Shagdarsuren E, Kelm M, Zernecke A & Weber C (2008). Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction. J Cell Mol Med 12, 496-506.
27. Lindsey M, Wedin K, Brown MD, Keller C, Evans AJ, Smolen J, Burns AR, Rossen RD, Michael L & Entman M (2001). Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 103, 2181-2187.
28. Matsumura S-I (2005). Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115, 599-609.
29. Maxwell MP, Hearse DJ & Yellon DM (1987). Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21, 737-746.
30. Moon C, Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG & Talan MI (2003). Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 100, 11612-11617.
31. Naseem RH, Meeson AP, Michael DiMaio J, White MD, Kallhoff J, Humphries C, Goetsch SC, De Windt LJ, Williams MA, Garry MG & Garry DJ (2007). Reparative myocardial mechanisms in adult C57BL/6 and MRL mice following injury. Physiol Genomics 30, 44-52.
32. Oh Y-S, Thomson LEJ, Fishbein MC, Berman DS, Sharifi B & Chen P-S (2004). Scar formation after ischemic myocardial injury in MRL mice. Cardiovasc Pathol 13, 203-206.
33. Pattanapanyasat K, Pengruangrojanachai V, Thepthai C, Suwanagool S & Wasi C (1994). Flow cytometric three-color determination of CD4 T-lymphocytes on blood specimens from AIDS patients who have a large number of contaminating non-lymphocytes. Asian Pac J Allergy Immunol 12, 105-109.
34. Pfeffer JM, Pfeffer MA, Fletcher PJ & Braunwald E (1991). Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol Heart Circ Physiol 260, H1406-H1414.
35. Pfeffer MA & Braunwald E (1990). Ventricular remodeling after myocardial infarction. Circulation 81, 1161-1172.
36. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA & Braunwald E (1979). Myocardial infarct size and ventricular function in rats. Circ Res 44, 503-512.
37. Reffelmann T, Hale SL, Dow JS & Kloner RA (2003). No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 108, 2911-2917.
38. Robey TE & Murry CE (2008). Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol 17, 6-13.
39. Roubille F, Combes S, Leal-Sanchez J, Barrere C, Cransac F, Sportouch-Dukhan C, Gahide G, Serre I, Kupfer E, Richard S, Hueber A-O, Nargeot J, Piot C & Barrere-Lemaire S (2007). Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury. Circulation 116, 2709-2717.
40. Smyth GK (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article 3.
41. Sun M, Dawood F, Wen W-H, Chen M, Dixon I, Kirshenbaum LA & Liu PP (2004). Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110, 3221-3228.
42. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y & Yacoub MH (2001). Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104, I-308-I-313.
43. Tao Z-Y, Cavasin MA, Yang F, Liu Y-H & Yang X-P (2004). Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci 74, 1561-1572.
44. Ugur O, Kathryn AG, Kimberlee D-H, Edward M & William BS (2001). NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 222, 218-227.
45. van den Borne SWM, Cleutjens JPM, Hanemaaijer R, Creemers EE, Smits JFM, Daemen MJAP & Blankesteijn WM (2009). Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 18, 37-43.
46. van der Laan M & Pollard K (2001). A new algorithm for hybrid hierarchical clustering with visualization and the bootstrap. Division of Biostatistics, University of California, Berkeley, Technical Report No. 93.
47. Walz A, Dewald B, von Tscharner V & Baggiolini M (1989). Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 170, 1745-1750.
48. Wu Z & Irizarry RA (2004). Preprocessing of oligonucleotide array data. Nat Biotech 22, 656-658.
49. Yang F, Liu Y-H, Yang X-P, Xu J, Kapke A & Carretero OA (2002). Myocardial infarction and cardiac remodelling in mice. Exp Physiol 87, 547-555.
50. Yang X, Khosravi-Far R, Chang HY & Baltimore D (1997). Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076.
51. Yao Y-Y, Yin H, Shen B, Chao L & Chao J (2007). Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regul Pept 140, 12-20.